These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion protein. Liu H; Wu BH; Rowse GJ; Emtage PC Clin Vaccine Immunol; 2007 Aug; 14(8):1013-23. PubMed ID: 17596433 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7. Chu NR; Wu HB; Wu T; Boux LJ; Siegel MI; Mizzen LA Clin Exp Immunol; 2000 Aug; 121(2):216-25. PubMed ID: 10931134 [TBL] [Abstract][Full Text] [Related]
5. A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals. Palefsky JM; Berry JM; Jay N; Krogstad M; Da Costa M; Darragh TM; Lee JY AIDS; 2006 May; 20(8):1151-5. PubMed ID: 16691066 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7. Chu NR; Wu HB; Wu TC; Boux LJ; Mizzen LA; Siegel MI Cell Stress Chaperones; 2000 Nov; 5(5):401-5. PubMed ID: 11189443 [TBL] [Abstract][Full Text] [Related]
8. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins. Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932 [TBL] [Abstract][Full Text] [Related]
9. Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. Einstein MH; Kadish AS; Burk RD; Kim MY; Wadler S; Streicher H; Goldberg GL; Runowicz CD Gynecol Oncol; 2007 Sep; 106(3):453-60. PubMed ID: 17586030 [TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus vaccines. Stanley MA Curr Opin Mol Ther; 2002 Feb; 4(1):15-22. PubMed ID: 11883690 [TBL] [Abstract][Full Text] [Related]
11. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Michel N; Osen W; Gissmann L; Schumacher TN; Zentgraf H; Müller M Virology; 2002 Mar; 294(1):47-59. PubMed ID: 11886264 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic, therapeutic and anti-metastatic effects of an HPV-16mE6Delta/mE7/TBhsp70Delta fusion protein vaccine in an animal model. Qian X; Lu Y; Liu Q; Chen K; Zhao Q; Song J Immunol Lett; 2006 Feb; 102(2):191-201. PubMed ID: 16242781 [TBL] [Abstract][Full Text] [Related]
13. Comparison of HPV DNA vaccines employing intracellular targeting strategies. Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791 [TBL] [Abstract][Full Text] [Related]
14. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response. Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545 [TBL] [Abstract][Full Text] [Related]
15. Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101. Klencke B; Matijevic M; Urban RG; Lathey JL; Hedley ML; Berry M; Thatcher J; Weinberg V; Wilson J; Darragh T; Jay N; Da Costa M; Palefsky JM Clin Cancer Res; 2002 May; 8(5):1028-37. PubMed ID: 12006515 [TBL] [Abstract][Full Text] [Related]
16. CoVal fusions: a therapeutic vaccine platform using heat shock proteins to treat chronic viral infection and cancer. Neefe JR; Chu NR; Mizzen L Dev Biol (Basel); 2004; 116():193-200; discussion 229-36. PubMed ID: 15603193 [TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immune responses and protective efficacy against infection with Mycobacterium tuberculosis induced by Hsp65 and hIL-2 fusion protein in mice. Shi C; Yuan S; Zhang H; Zhang T; Wang L; Xu Z Scand J Immunol; 2009 Feb; 69(2):140-9. PubMed ID: 19144078 [TBL] [Abstract][Full Text] [Related]
18. Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity. Li D; Li H; Zhang P; Wu X; Wei H; Wang L; Wan M; Deng P; Zhang Y; Wang J; Liu Y; Yu Y; Wang L Eur J Immunol; 2006 May; 36(5):1324-36. PubMed ID: 16619287 [TBL] [Abstract][Full Text] [Related]
19. [Improved efficacy of P277 fused to heat shock protein 65 of Mycobacterium tuberculosis against diabetes in nonobese diabetic mice]. Zhu A; Lu Y; Jin L; Wu J; Li T; Liu J Sheng Wu Gong Cheng Xue Bao; 2008 Apr; 24(4):640-5. PubMed ID: 18616176 [TBL] [Abstract][Full Text] [Related]
20. Animal models for development of therapeutic HPV16 vaccines (review). Bubeník J Int J Oncol; 2002 Jan; 20(1):207-12. PubMed ID: 11743666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]